Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kara Lynn Davis

Clinical trials sponsored by Kara Lynn Davis, explained in plain language.

Engineered immune cells take aim at tough childhood cancers

Disease control Completed

This early-phase trial tested whether a new type of immune cell therapy (CD22 CAR T cells) could be safely made and given to 10 children and young adults whose B-cell leukemia or lymphoma had come back or stopped responding to treatment. The therapy uses the patient's own immune …

Phase: PHASE1 • Sponsor: Kara Lynn Davis • Aim: Disease control

Last updated Jun 15, 2026 18:54 UTC